The EU's decision to delay parts of the AI Act will give healthcare organisations additional time to prepare for full compliance obligations. For digital health leaders and governance teams managing complex implementation programmes, that breathing room is welcome. But the cyber risk timeline did not move. AI adoption in healthcare is accelerating regardless of the regulatory schedule, and the attack surface is expanding with it. The commercial context driving this acceleration, particularly the volume of capital flowing into the US digital health market and the consolidation patterns following it, is covered in detail in our article on what the US digital health market means for European healthtech companies. For every healthcare organisation deploying ambient AI, clinical decision support tools, or workflow automation platforms, the cyber security implications of that deployment are live now, not deferred to a future compliance date.
Understanding the gap between where AI adoption is and where healthcare cyber resilience needs to be is one of the most pressing strategic challenges facing healthcare executives and CIOs in 2026.
The pace of clinical AI deployment across health systems has moved well beyond the pilot phase in many organisations. The tools being deployed are not peripheral productivity aids. They are becoming embedded in the operational core of healthcare delivery.
Ambient AI tools that capture and structure clinical conversations in real time are now in active use across a growing number of trusts and health systems. Clinical copilots supporting diagnostic reasoning, documentation, and referral decisions are following. These tools sit at the intersection of patient data, clinical workflow, and operational continuity. Their presence in the clinical environment creates new data flows, new integration points, and new dependencies that did not exist in the organisation's original security architecture.
AI-powered triage tools are changing how patients are assessed and prioritised at the front door of healthcare services. Workflow automation platforms are being integrated into reimbursement processes, scheduling systems, and administrative functions that underpin clinical operations. Many of these tools already touch patient data, reimbursement workflows, and core clinical systems simultaneously.
The breadth of that footprint means that a compromise affecting one of these platforms is not a contained IT incident. It is an operational risk event with patient safety implications.
The EU AI Act delay is a regulatory adjustment, not a risk adjustment. The AI tools being deployed in healthcare environments today carry cyber risk from the moment of integration, irrespective of where the compliance timeline sits.
Every AI tool integrated into a clinical environment extends the organisation's attack surface. Each new integration point, each API connection to a third-party platform, and each data pipeline feeding an AI model represents a potential entry vector for a threat actor. Healthcare organisations that were managing a defined and relatively stable set of system dependencies two years ago are now managing a significantly more complex and rapidly evolving technology estate.
The challenge is not that any individual AI tool is insecure. It is that the aggregate effect of multiple rapid deployments, each with its own integration architecture and third-party dependencies, can outpace the organisation's ability to assess and govern the cumulative risk.
AI adoption in healthcare is largely being delivered through third-party platforms and suppliers. Health systems are not building ambient AI or clinical copilot capability in-house. They are procuring it, integrating it, and becoming operationally dependent on it within compressed timescales. Each third-party AI dependency introduces supply chain cyber risk that requires active governance, not passive trust in the supplier's own security assurances.
The NIS Regulations and the DSP Toolkit both place accountability for third-party security at the organisational level. A health system whose AI supplier experiences a significant security incident cannot transfer the regulatory and reputational consequences of that incident to the supplier. The accountability remains with the organisation that made the procurement decision and holds the patient data relationship.
The combination of expanding attack surfaces and growing third-party dependencies is creating increasing operational risk inside clinical environments that are designed around uptime, trust, and patient safety. A ransomware incident that takes down a workflow automation platform integrated into theatre scheduling, reimbursement processing, and electronic prescribing simultaneously is qualitatively different from a ransomware incident that affects a standalone administrative system. Healthcare cyber resilience frameworks that were designed before clinical AI integration need to be reassessed against the operational profile that integration has created.
The framing that cyber security is a technical function and AI adoption is a transformation function is no longer adequate for healthcare organisations deploying clinical AI at scale. The two disciplines are converging, and the organisations that recognise this earliest will build the most defensible AI environments.
Healthcare organisations deploying AI tools at speed need security architecture that keeps pace with deployment, not security reviews that follow months after go-live. That means integrating cyber risk assessment into the AI procurement and deployment process from the outset, rather than treating it as a post-deployment compliance activity.
It means asking, before a clinical AI tool goes live, how it handles patient data, what third-party systems it connects to, what happens to clinical operations if it becomes unavailable, and whether the supplier's security posture has been independently assessed against the risk it represents in a clinical environment.
Healthcare organisations need governance structures that can hold clinical AI risk alongside patient safety risk and cyber security risk in a single, coherent framework. Currently, in most organisations, these workstreams operate separately. AI deployment is governed through digital transformation or clinical informatics. Cyber security is governed through the IT security function. Patient safety is governed through clinical governance.
A significant AI-related cyber incident in a clinical environment will not respect those organisational boundaries. The response will need to be coordinated across all three domains simultaneously, and the preparation for that response needs to happen before the incident, not during it.
At Santegic, we work with healthcare organisations to bring these workstreams together, assessing the cyber risk implications of clinical AI deployment and building the governance frameworks that allow AI adoption to proceed with confidence rather than accumulated, unexamined risk.
The EU AI Act delay does not reduce the urgency of addressing cyber risk in clinical AI environments. If anything, it reinforces it. Organisations that use the extended compliance window to deploy more AI without building the corresponding cyber resilience foundations are not managing risk. They are deferring it.
Three actions are worth prioritising now.
Conducting a clinical AI asset audit so the organisation has a clear and current picture of every AI tool deployed or in procurement, what data it accesses, what systems it integrates with, and what the operational dependency looks like if it becomes unavailable.
Applying third-party AI risk assessment to every significant supplier, with particular attention to those whose platforms touch patient data, reimbursement workflows, or clinical operations. Supplier security assurances are a starting point, not a conclusion.
Reviewing whether existing healthcare cyber security strategy and incident response plans account for the operational profile created by clinical AI integration, including the dependencies, the data flows, and the patient safety implications of AI platform unavailability.
The EU AI Act delay is a useful adjustment to a complex regulatory programme. It does not change the risk profile of AI adoption in healthcare, and it does not extend the timeline by which healthcare organisations need to have addressed the cyber security implications of the AI tools already running in their clinical environments.
AI adoption in healthcare is accelerating. The attack surface is expanding. The third-party dependencies are growing. And the operational consequences of a cyber incident in an AI-integrated clinical environment are more significant than they were before that integration took place. Healthcare cyber resilience must develop at the same pace as clinical AI deployment, not at the pace of regulatory compliance schedules.
If your organisation is deploying clinical AI and needs to ensure its healthcare cyber security strategy reflects the risk that deployment creates, Santegic's healthcare consulting services are available to help. Get in touch to discuss how cyber expertise can be built into your AI adoption programme from the ground up.
Santegic Cyber provides specialist healthcare cyber resilience advisory, clinical AI risk assessment, and third-party security governance services to health organisations, health systems, and digital health suppliers across the UK and Ireland.
One conversation. The right expertise.
